This year saw outstanding results from the hospital operators, in particular, Ramsay Healthcare (RHC). Results were at the top end of consensus forecasts, and expectations are for continued robust growth. Over the last 20 year, RHC has produced an average of 16% compound earnings growth, and this looks like it will continue; we maintain our add rating. However, it's worth noting that Healthscope is trading at a lower multiple, and its growth profile looks more attractive. We also have an add recommendation on Healthscope as the growth profile should increase share price performance. In the video below, Morgans Senior Analyst, Scott Power, provides an update on the aged care sector, the IVF operators, Impedimed, and Nanosonics.
Please sign in to comment on this wire.